Viewing StudyNCT00317772



Ignite Creation Date: 2024-05-05 @ 4:46 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00317772
Status: COMPLETED
Last Update Posted: 2022-02-07
First Post: 2006-04-21

Brief Title: Topotecan and Gefitinib Iressa for Ovarian Peritoneal or Fallopian Tube Cancer
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-09-02
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-04
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-04
Completion Date Type: ACTUAL
First Submit Date: 2006-04-21
First Submit QC Date: April 21 2006
Study First Post Date: 2006-04-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-02-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2021-10-07
Disp First Submit QC Date: October 7 2021
Disp First Post Date: 2021-10-14
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-01-11
Last Update Post Date: 2022-02-07
Last Update Post Date Type: ACTUAL